EC Development, Inc. (EXDI):
EC Development, Inc. Signs Agreement to Supply Tahoe CMS Technologies to Atlantis Internet Group Corporation
SHAWNEE, OK — (MARKET WIRE) — 06/20/11 — EC Development, Inc. (PINKSHEETS: ECDI) announced today that it has entered into a supply and distribution agreement with Atlantis Internet Group Corporation (ATIG). As part of the agreement, Atlantis Internet Group will market, sell and support the EC Development Tahoe technologies through their “Tribal Gaming Network,” the Native American version of their patent pending ” Casino Gateway Network ,” a technology that allows tribal casinos to participate in the largest online poker network in the U.S. Tribal Gaming Network vendors will be able to operate within the network securely through a proprietary EC Development format that funnels and manages their data through a central database, much like ecommerce providers. The company anticipates over 5,000 games with revenues in excess of $5MM over the duration of the five year agreement.
BizRocket.com, Inc. (BZRT)
BizRocket.com, Inc., to Sign MOU Toward Acquisition of B2B Internet Marketing Firm
CORAL SPRINGS, Fla. –(BUSINESS WIRE)– BizRocket.com, Inc. (OTC Pink Sheets: BZRT) announces today that it is currently drafting its Memorandum of Understanding toward the acquisition of a full-service Internet E-Mail Marketing Company that specializes in full B2B Internet Marketing services. The company currently has a roster of business customers across the United States .
The MOU outlines the agreement details to include a 40% EBITA participation for Bizrocket.com, Inc. Company execs feel strongly that aside from adding an attractive source of revenues for the company in expanding its overall business offerings, it will also undoubtedly aid in enhancing membership subscriptions and marketing initiatives for the companys websites, including www.KidzRocket.com, Bizrockets patent pending, safe pre-teen social networking website. KidzRocket.com is gaining continued recognition as the safest pre-teen social networking website described by execs as a FBL-facebook-like for pre-teens.
The Company expects revenues from this particular asset to generate in excess of $2.0 million for its first year. B2B and B2C E-mail marketing is part of a multi-billion dollar industry and BizRocket.com, Inc. execs is confident it can become a significant industry participant with unique crossover opportunity in its business models toward possible buyouts from tech and media giants. Pre-teen target marketing is on the rise as demonstrated by the recent acquisition of sites like Club Penguin by Disney recently for a deal involving up to $700 million . Likewise, social coupon sites have tremendous potential. Earlier this month, Groupon initiated paperwork for an IPO filed for $750 million dollars with a valuation at near $20 billion dollars .
AISystems, Inc. (ASYI):
Major US Airline Begins Beta Testing AISystems’ jetEngine(TM) Business Planning Suite
TORONTO, ONTARIO — (MARKET WIRE) — 06/20/11 — AISystems, Inc. (OTCBB: ASYI) (“AISystems” or the “Company”), creator of jetEngine™, a revolutionary business platform software system for the airline industry, is pleased to announce a major US airline is beta testing the jetEngine™ Business Planning Suite (“jetEngine™ BPS”).
Major Beta Customer
In response to the launch of its jetEngine™ Beta Customer Program, AISystems has been beta testing with one of the largest airlines in the United States .
“We are excited to take this next step with a major airline” stated Stephen C. Johnston , President and CEO of AISystems . “It shows great progress for us and really lets us show the power of jetEngine™ BPS. At this time due to a non-disclosure agreement we are unable to disclose the name of the airline beta testing the jetEngine™ BPS. We will disclose the airline name as soon as we are able to.”
Senesco Technologies, Inc. (SNT):
Senesco Technologies Told by FDA It May Proceed SNS01-T IND is Open Business
BRIDGEWATER, N.J. –(BUSINESS WIRE)– Senesco Technologies, Inc. (Senesco or the Company) (NYSE Amex: SNT) today announced that the Company has been told by the U.S. Food and Drug Administration (the FDA) that all clinical hold issues have been satisfactorily addressed and the FDA has removed the clinical hold on Senescos Investigational New Drug (IND) application. After the Companys supplier provided the requested update to the suppliers Drug Master File (DMF) and satisfactorily addressed all FDA questions, Senesco was informed by the FDA that it may proceed with its first-in-class clinical study in multiple myeloma. Senescos IND for SNS01-T is open.